Skip to main content

Table 1 Comparison of the basic characteristics of patients with EGC between the delayed bleeding group and the nonbleeding group

From: External validation of the BEST-J score and a new risk prediction model for ESD delayed bleeding in patients with early gastric cancer

  Nonbleeding group
(n = 417)
Delayed bleeding group (n = 27) χ2 or t value P value
Age (years, mean ± SD) 63.08 ± 9.317 63.00 ± 12.175 0.041 0.135
Sex [n (%)]    0.177 0.674
 Male 293 (70.3) 20 (74.3)   
 Female 124 (29.7) 7 (25.9)   
Hypertension [n (%)]    0.073 0.787
 No 258 (61.9) 16 (59.3)   
 Yes 159 (38.1) 11 (40.7)   
Coronary heart disease [n (%)]   NA 1.000
 No 376 (90.2) 25 (92.6)   
 Yes 41 (9.8) 2 (7.4)   
Diabetes [n (%)]    NA 0.444
 No 341 (81.8) 24 (88.9)   
 Yes 76 (18.2) 3 (11.1)   
Anticoagulant medication history [n (%)]   NA 0.172
 No 415 (99.5) 26 (96.3)   
 Yes 2 (0.5) 1 (0.2)   
Antiplatelet medication history [n (%)]   NA 1.000
 No 376 (90.2) 25 (92.6)   
 Yes 41 (9.8) 2 (7.4)   
Antidepressant medication history [n (%)]   NA 0.223
 No 414 (99.3) 26 (96.3)   
 Yes 3 (0.7) 1 (0.2)   
Proprietary Chinese medicine history [n (%)] NA 0.614
 No 402 (96.4) 27 (100.0)   
 Yes 15 (3.6) 0 (0.0)   
Smoking [n (%)]   4.072 0.044*
 No 252 (60.4) 11 (40.7)   
 Yes 165 (39.6) 16 (59.3)   
Drinking [n (%)]   1.904 0.168
 No 271 (65.0) 14 (51.9)   
 Yes 146 (35.0) 13 (48.1)   
Family history of digestive tract tumors [n (%)] 1.188 0.276
 No 317 (76.0) 23 (85.2)   
 Yes 100 (24.0) 4 (14.8)   
  1. EGC, early gastric cancer; NA, not available due to Fisher’s exact test; SD, standard deviation
  2. *P < 0.05